top of page
San Francisco

KASBP
SAN FRANCISCO

KASBP-SF (Korean American Society in Biotech and Pharmaceuticals) is
a non-profit organization for Korean biopharmaceutical professionals
in the San Francisco Bay area

Learn more
Key events

KASBP-SF 2024 December Seminar

"Overview of Drug Discovery and Development" Seminar Series

  • Title: ADME/PK/Efficacy/Tox 측면에서 바라본 ADC의 오해와 진실

  • Speaker: Young G. Shin, PhD.
                   (Professor, College of Pharmacy, Chungnam National University)
     

  • When: 12/17/2024 (Tuesday), 6:00 pm

  • Where: Millbrae Library Meeting Rooms A/B (1 Library Avenue, Millbrae, CA 94030) (기존 세미나 장소와 다른 곳이므로 유의해 주시기 바랍니다)

  • Registration and more information: RSVP Link

KASBP-SF Symposium 2025

When: January 11th (Saturday), 2025, 9AM - 6PM (PST)
Where: Embassy Suites by Hilton San Francisco Airport
              (250 Gateway Blvd, South San Francisco, CA 94080)

Click Here for Details and Registration

Membership

Sign up for KASBP-SF membership

KASBP-SF membership is free!

Sign up to receive announcements on future events.

Members

200

Companies

90

Years

15

Jobs & Announcement

J&A
People

People

We are a community of professionals in biotech companies, including
Genentech
Merck
Gilead
Amgen
Novartis
AstraZeneca
BMS
Biomarin
Abbvie
Exelixis
Denali
Abbott
Janssen
BeiGene
Santen
Thermo Fisher
Nurix
Novo Nordisk
Verily
23andMe
Committe

Meet the committee

President

President Team

Finance Team



Science Team







Public Relations / Membership Team









​


Councilor
 
윤오규 Oh Kyu Yoon

김상엽 Sang Yeop Kim

​조   향 Hyang Jo

이동은 Agatha Lee

한진환 Jin-Hwan Han

조효석 Hyosuk Cho

김수진 Soojin Kim

이성진 Sungjin Lee

장아람 Aram Chang

황승용 Seung Yong Hwang

이현철 Hyuncheol Lee

김기철 Kicheol Kim

박지원 Ji Won Park

​김양준 Yang-Joon Kim


임한조 Hanjo Lim 

마성훈 ​Sunghoon Ma

정준원 Joon Won Jeong

정가영 Claire Jeong
Sponsor

Sponsors

Gold

Silver

Bronze

Blog Posts

Posts Coming Soon
Explore other categories in this blog or check back later.
blog post
Contact us if you have any questions/suggestions

Success! Message received.

Subscribe
bottom of page